Intravenous iron staining: real-world incidence, preventability, and mitigation tools from a long-term quality improvement project
The incidence rate of IV iron staining in a real-world clinical setting is 0.31%. There was increased compliance with several best practice principles and 86% of stains were preventable. Early identification and intervention of potential staining incidents results in smaller iron stains for patients. Quality improvement tools developed for this project can contribute to patient outcomes internationally.
Authors
- Narges Alizadeh (ORCID: https://orcid.org/0000-0003-0850-488X)
- Masuo KASHIWAGI
- Christopher Freeman (ORCID: https://orcid.org/0000-0001-6429-0316)
- Martin Canning (ORCID: https://orcid.org/0000-0002-6216-8728)
- Jodie Hillen (ORCID: https://orcid.org/0000-0001-9269-9397)
Institutions
- The University of Queensland (AU)
- Royal Brisbane and Women's Hospital (AU)
- Mayne Pharma (Australia) (AU)
Publication Details
- Journal
- International Journal for Quality in Health Care
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1093/intqhc/mzae096
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00